Contract 36F79721D0236
Leadiant Biosciences, Inc. · Department Of Veterans Affairs · September 11, 2024
Leadiant Biosciences, Inc. was awarded a federal contract by Department Of Veterans Affairs on September 11, 2024 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It was awarded under full and open competition. The contract has been modified 7 times since the base award It uses firm fixed-price contract pricing. The most recent modification was on December 19, 2025. If all options are exercised, the contract could reach $4.46 million.
Contract details
- PIID
- 36F79721D0236
- Award type
- Fss
- Pricing
- Fixed Price With Economic Price Adjustment
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- September 11, 2024
- Latest action
- December 19, 2025
Description
NDC CHANGE.
Modification timeline
-
December 19, 2025Mod P00016 · Supplemental Agreement For Work Within Scope$0
-
December 19, 2025Mod P00016$0
-
December 10, 2025Mod P00015 · Supplemental Agreement For Work Within ScopeDELETION.$0
-
November 19, 2025Mod P00014 · Supplemental Agreement For Work Within Scope2026 PL.$0
-
October 16, 2025Mod P00013 · Supplemental Agreement For Work Within ScopeDELETION.$0
-
July 18, 2025Mod P00012 · Supplemental Agreement For Work Within Scope$0
-
July 16, 2025Mod P00011 · Other Administrative ActionSAF UPDATE.$0
-
September 11, 2024Mod P00009 · Supplemental Agreement For Work Within Scope$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Petnet Solutions, Inc. | Department Of Veterans Affairs | April 1, 2026 | $387.4K |
| Eli Lilly And Company | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Exelan Pharmaceuticals Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Cardinal Health 414, Llc | Department Of Veterans Affairs | April 1, 2026 | $122.9K |
| Guardian Pharmacy Of Indianapolis Nuclear, Llc | Department Of Veterans Affairs | April 1, 2026 | $0 |
| Jubilant Draximage Inc | Department Of Veterans Affairs | April 1, 2026 | $0 |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 36F79721D0236?
Contract 36F79721D0236 is a federal contract awarded to Leadiant Biosciences, Inc. by Department Of Veterans Affairs on September 11, 2024 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 7 times since the base award.
Who won contract 36F79721D0236?
Leadiant Biosciences, Inc. won contract 36F79721D0236 from Department Of Veterans Affairs.
How much is contract 36F79721D0236 worth?
Contract 36F79721D0236 has obligated $0 to date but carries a potential ceiling of $4.46 million if fully funded and all options are exercised.